Thioredoxin-binding protein-2 (TBP-2/VDUP1/TXNIP) regulates T-cell sensitivity to glucocorticoid during HTLV-I-induced transformation

Leukemia

Volumn 25, Issue 3, 2011, Pages 440-448

  Chen, Z ^a   Lopez Ramos, D A ^a   Yoshihara, E ^a   Maeda, Y ^b   Masutani, H ^a   Sugie, K ^a   Maeda, M ^a   Yodoi, J ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

apoptosis; ATL; glucocorticoid; glucocorticoid receptor; HTLV I; thioredoxin binding protein 2 thioredoxin interacting protein

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; INTERLEUKIN 2; MIFEPRISTONE; THIOREDOXIN INTERACTING PROTEIN; VORINOSTAT;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TARGETING; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMIA CELL; LYMPHOCYTE TRANSFORMATION; LYMPHOID CELL LINE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; T CELL LEUKEMIA; T LYMPHOCYTE;

EID: 79952450229     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.286     Document Type: Article

References (38)

1. Yodoi J, Takatsuki K, Masuda T. Letter: two cases of T-cell chronic lymphocytic leukemia in Japan. N Engl J Med 1974; 290: 572-573. .
2. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977; 50: 481-492. . (Pubitemid 8180432)
3. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415-7419. . (Pubitemid 11131140)
4. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 6476-6480. . (Pubitemid 12179735)
5. Popovic M, Reitz Jr MS, Sarngadharan MG, Robert-Guroff M, Kalyanaraman VS, Nakao Y et al. The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group. Nature 1982; 300: 63-66. . (Pubitemid 12005055)
6. Okamoto T, Ohno Y, Tsugane S, Watanabe S, Shimoyama M, Tajima K et al. Multi-step carcinogenesis model for adult T-cell leukemia. Jpn J Cancer Res 1989; 80: 191-195. . (Pubitemid 20027205)
7. Bamford RN, Battiata AP, Burton JD, Sharma H, Waldmann TA. Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region /IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation. Proc Natl Acad Sci USA 1996; 93: 2897-2902. .
8. Migone TS, Lin JX, Cereseto A, Mulloy JC, O'Shea JJ, Franchini G et al. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 1995; 269: 79-81. .
9. Maeda M, Arima N, Daitoku Y, Kashihara M, Okamoto H, Uchiyama T et al. Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia. Blood 1987; 70: 1407-1411. . (Pubitemid 18026146)
10. Maeda M, Shimizu A, Ikuta K, Okamoto H, Kashihara M, Uchiyama T et al. Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement. J Exp Med 1985; 162: 2169-2174. . (Pubitemid 16149702)
11. Maeda M. Human T lymphotropic virus type-I (HTLV-I) immortalizes human T cells in vitro-its implication in the pathogenesis of adult T cell leukemia (ATL). Hum Cell 1992; 5: 70-78. .
12. Sionov RV, Spokoini R, Kfir-Erenfeld S, Cohen O, Yefenof E. Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis. Adv Cancer Res 2008; 101: 127-248. .
13. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington JrWet al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 2009; 27: 453-459. .
14. Taylor GP, Matsuoka M. Natural history of adult T-cell leukemia/ lymphoma and approaches to therapy. Oncogene 2005; 24: 6047-6057. . (Pubitemid 43086122)
15. Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ 2004; 11(Suppl 1): S45-S55. . (Pubitemid 39136798)
16. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354: 166-178. . (Pubitemid 43076714)
17. Chin KT, Chun AC, Ching YP, Jeang KT, Jin DY. Human T-cell leukemia virus oncoprotein tax represses nuclear receptordependent transcription by targeting coactivator TAX1BP1. Cancer Res 2007; 67: 1072-1081. .
18. Doucas V, Evans RM. Human T-cell leukemia retrovirus-Tax protein is a repressor of nuclear receptor signaling. Proc Natl Acad Sci USA 1999; 96: 2633-2638. . (Pubitemid 29148769)
19. Fung MM, Chu YL, Fink JL, Wallace A, McGuire KL. IL-2- and STAT5-regulated cytokine gene expression in cells expressing the Tax protein of HTLV-1. Oncogene 2005; 24: 4624-4633. . (Pubitemid 41032600)
20. Higuchi M, Tsubata C, Kondo R, Yoshida S, Takahashi M, Oie M et al. Cooperation of NF-kappaB2/p100 activation and the PDZ domain binding motif signal in human T-cell leukemia virus type 1 (HTLV-1) Tax1 but not HTLV-2 Tax2 is crucial for interleukin-2- independent growth transformation of a T-cell line. J Virol 2007; 81: 11900-11907. . (Pubitemid 47623821)
21. Teshigawara K, Maeda M, Nishino K, Nikaido T, Uchiyama T, Tsudo M et al. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. J Mol Cell Immunol 1985; 2: 17-26. . (Pubitemid 15112482)
22. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H et al. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 1999; 274: 21645-21650. .
23. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998; 17: 2596-2606. . (Pubitemid 28221195)
24. Chen CL, Lin CF, Chang WT, Huang WC, Teng CF, Lin YS. Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin- interacting protein-mediated pathway. Blood 2008; 111: 4365-4374. .
25. Mukherjee A, Martin SG. The thioredoxin system: a key target in tumour and endothelial cells. Br J Radiol 2008; 81 (Spec No. 1): S57-S68. .
26. Watanabe R, Nakamura H, Masutani H, Yodoi J. Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2. Pharmacol Ther 2010; 127: 261-270. .
27. Wang Z, Rong YP, Malone MH, Davis MC, Zhong F, Distelhorst CW. Thioredoxin-interacting protein (txnip) is a glucocorticoid- regulated primary response gene involved in mediating glucocorticoid-induced apoptosis. Oncogene 2006; 25: 1903-1913. .
28. Nishinaka Y, Nishiyama A, Masutani H, Oka S, Ahsan KM, Nakayama Y et al. Loss of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 in human T-cell leukemia virus type I-dependent T-cell transformation: implications for adult T-cell leukemia leukemogenesis. Cancer Res 2004; 64: 1287-1292. . (Pubitemid 38235595)
29. Ahsan MK, Masutani H, Yamaguchi Y, Kim YC, Nosaka K, Matsuoka M et al. Loss of interleukin-2-dependency in HTLV-Iinfected T cells on gene silencing of thioredoxin-binding protein-2. Oncogene 2006; 25: 2181-2191. .
30. Takemoto S, Mulloy JC, Cereseto A, Migone TS, Patel BK, Matsuoka M et al. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci USA 1997; 94: 13897-13902. . (Pubitemid 28009681)
31. Junn E, Han SH, Im JY, Yang Y, Cho EW, Um HD et al. Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol 2000; 164: 6287-6295. . (Pubitemid 30408809)
32. Nishiyama A, Masutani H, Nakamura H, Nishinaka Y, Yodoi J. Redox regulation by thioredoxin and thioredoxin-binding proteins. IUBMB Life 2001; 52: 29-33. . (Pubitemid 33769666)
33. Butler LM, Zhou X, Xu WS, Scher HI, Rifkind RA, Marks PA et al. The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci USA 2002; 99: 11700-11705. . (Pubitemid 34994462)
34. Kaimul AM, Nakamura H, Masutani H, Yodoi J. Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. Free Radic Biol Med 2007; 43: 861-868. . (Pubitemid 47223630)
35. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxininteracting protein links oxidative stress to inflammasome activation. Nat Immunol 2010; 11: 136-140. .
36. Oka S, Liu W, Masutani H, Hirata H, Shinkai Y, Yamada S et al. Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome. FASEB J 2006; 20: 121-123. . (Pubitemid 43100487)
37. Richon VM, Sandhoff TW, Rifkind RA, Marks PA. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci USA 2000; 97: 10014-10019. .
38. Nosaka K, Maeda M, Tamiya S, Sakai T, Mitsuya H, Matsuoka M. Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia. Cancer Res 2000; 60: 1043-1048. (Pubitemid 30129543)